TERM ID="NYU_TERM_1" STRING="Available therapies" FREQUENCY=1 START=967 END=986 LEMMA="AVAILABLE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Bone metastasis" FREQUENCY=1 START=248 END=263 LEMMA="BONE METASTASI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_3" STRING="Important mediators" FREQUENCY=1 START=742 END=761 LEMMA="IMPORTANT MEDIATOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="Important mediators of pathologic bone metabolism" FREQUENCY=1 START=742 END=791 LEMMA="PATHOLOGIC BONE METABOLISM IMPORTANT MEDIATOR" LEMMA_FREQUENCY=1 HEAD_TERM="Important mediators" HEAD_LEMMA="IMPORTANT MEDIATOR"
TERM ID="NYU_TERM_5" STRING="Osteoporosis" FREQUENCY=1 START=384 END=396 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Osteoporotic bone loss" FREQUENCY=1 START=566 END=588 LEMMA="OSTEOPOROTIC BONE LOSS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="RANKL" FREQUENCY=1 START=844 END=849 LEMMA="RANK LIGAND" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="androgen-deprivation therapy" FREQUENCY=1 START=435 END=463 LEMMA="ANDROGEN-DEPRIVATION THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="aromatase inhibition" FREQUENCY=1 START=485 END=505 LEMMA="AROMATASE INHIBITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="bone metastasis" FREQUENCY=1 START=1031 END=1046 LEMMA="BONE METASTASI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_11" STRING="bone resorption" FREQUENCY=1 START=669 END=684 LEMMA="BONE RESORPTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="consequences" FREQUENCY=1 START=419 END=431 LEMMA="CONSEQUENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="consequences of androgen-deprivation therapy" FREQUENCY=1 START=419 END=463 LEMMA="ANDROGEN-DEPRIVATION THERAPY CONSEQUENCE" LEMMA_FREQUENCY=1 HEAD_TERM="consequences" HEAD_LEMMA="CONSEQUENCE"
TERM ID="NYU_TERM_14" STRING="consequences of androgen-deprivation therapy for prostate cancer" FREQUENCY=1 START=419 END=483 LEMMA="PROSTATE CANCER ANDROGEN-DEPRIVATION THERAPY CONSEQUENCE" LEMMA_FREQUENCY=1 HEAD_TERM="consequences of androgen-deprivation therapy" HEAD_LEMMA="ANDROGEN-DEPRIVATION THERAPY CONSEQUENCE"
TERM ID="NYU_TERM_15" STRING="factor kappa B ligand" FREQUENCY=1 START=885 END=906 LEMMA="FACTOR KAPPA B LIGAND" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="hypercalcemia" FREQUENCY=1 START=219 END=232 LEMMA="HYPERCALCEMIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="hypercalcemia of malignancy" FREQUENCY=1 START=219 END=246 LEMMA="MALIGNANCY HYPERCALCEMIA" LEMMA_FREQUENCY=1 HEAD_TERM="hypercalcemia" HEAD_LEMMA="HYPERCALCEMIA"
TERM ID="NYU_TERM_18" STRING="malignancy" FREQUENCY=1 START=236 END=246 LEMMA="MALIGNANCY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="managing bone loss" FREQUENCY=1 START=53 END=71 LEMMA="MANAGING BONE LOSS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="manifestations" FREQUENCY=1 START=332 END=346 LEMMA="MANIFESTATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="metastasis" FREQUENCY=1 START=76 END=86 LEMMA="METASTASI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="myeloid cells" FREQUENCY=1 START=952 END=965 LEMMA="MYELOID CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="myeloma" FREQUENCY=1 START=375 END=382 LEMMA="MYELOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="oncology" FREQUENCY=1 START=43 END=51 LEMMA="ONCOLOGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="osteoblasts" FREQUENCY=1 START=823 END=834 LEMMA="OSTEOBLAST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="osteoclast differentiation" FREQUENCY=1 START=920 END=946 LEMMA="OSTEOCLAST DIFFERENTIATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="osteoclasts" FREQUENCY=1 START=729 END=740 LEMMA="OSTEOCLAST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="osteopenia" FREQUENCY=1 START=401 END=411 LEMMA="OSTEOPENIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="ovarian failure" FREQUENCY=1 START=549 END=564 LEMMA="OVARIAN FAILURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="pathologic bone metabolism" FREQUENCY=1 START=765 END=791 LEMMA="PATHOLOGIC BONE METABOLISM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="pathophysiologic pathway" FREQUENCY=1 START=628 END=652 LEMMA="PATHOPHYSIOLOGIC PATHWAY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="prostate" FREQUENCY=1 START=294 END=302 LEMMA="PROSTATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="prostate cancer" FREQUENCY=1 START=468 END=483 LEMMA="PROSTATE CANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="receptor activator" FREQUENCY=1 START=855 END=873 LEMMA="RECEPTOR ACTIVATOR" LEMMA_FREQUENCY=1
